HCPCS Level II › J codes J2249 Inj, remimazolam, 1 mgInjection, remimazolam, 1 mg
Medicare coverage: Carrier judgment Status: active (October 2026 file) Medicare pricing for J2249 Physician Fee Schedule (CY 2026, RVU26D) Status E: excluded from the PFS by regulation.
Payer policies and prior authorization for J2249 Payer coverage policies that name J2249 J2249 appears in 1 coverage policy from Aetna.
Payer Policy Role in policy Reviewed Document Aetna Injectable Medications (0020) listed, no stance (range J0278-J2543) Mar 5, 2026 payer document
Medicaid fee-for-service Prior authorization required or conditional in VT.
AZ: $2.32 (outpatient_hospital), effective Jul 1, 2026 IL: $11.10 (practitioner), effective Apr 1, 2026 IN: $1.96 (professional, Advanced Practice Nurse (85%), non-facility), effective Apr 1, 2025 KY: $0.00 (asc), effective Jan 1, 2026 MS: $2.32 (comprehensive), effective Jul 1, 2026 NE: $2.48 (injectables), effective Jul 1, 2026 OH: $2.21 (provider_administered_drugs), effective Jul 1, 2023 OK: $2.07 (physician, non-facility), effective Jul 1, 2026 TX: $2.23 (healthy_texas_women, Clinic/Group Practice, non-facility), effective Mar 1, 2026 VT: $0.00 (outpatient_hospital_opps), effective Feb 1, 2026 WA: $2.32 (professional_administered_drugs), effective Jul 1, 2026 WY: $0.00 (outpatient_hospital_apc, Children's Hospitals), effective Apr 1, 2026 From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.